BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24926347)

  • 1. Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis.
    Yu Y; Ding S; Liang Y; Zheng Y; Li W; Yang L; Zheng X; Jiang J
    Exp Ther Med; 2014 Jun; 7(6):1578-1582. PubMed ID: 24926347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer: Association with clinicopathological characteristics.
    Li J; Sun P; Huang T; He S; Li L; Xue G
    Medicine (Baltimore); 2021 Apr; 100(14):e25344. PubMed ID: 33832110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy.
    Jiang H; Wang H; Wang S; Pei Z; Fu Z; Fang C; Wang J; Lu Q; Wang E; Li J
    Mol Med Rep; 2015 May; 11(5):3523-32. PubMed ID: 25573098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.
    Cao Y; Zhang G; Wang P; Zhou J; Gan W; Song Y; Huang L; Zhang Y; Luo G; Gong J; Zhang L
    BMC Gastroenterol; 2017 Jan; 17(1):2. PubMed ID: 28056823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the mRNA expression of
    Sun S; Shi W; Wu Z; Zhang G; Yang BO; Jiao S
    Exp Ther Med; 2015 Sep; 10(3):937-941. PubMed ID: 26622418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.
    Han Y; Wang XB; Xiao N; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(5):2987-90. PubMed ID: 23803067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized chemotherapy guided by the expression of
    Li J; Sun P; Huang T; He S; Li L; Xue G
    Oncol Lett; 2021 Jan; 21(1):21. PubMed ID: 33240427
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.
    Tóth C; Sükösd F; Valicsek E; Herpel E; Schirmacher P; Renner M; Mader C; Tiszlavicz L; Kriegsmann J
    Int J Mol Med; 2017 Nov; 40(5):1457-1465. PubMed ID: 28949378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients.
    Xu YC; Zhang FC; Li JJ; Dai JQ; Liu Q; Tang L; Ma Y; Xu Q; Lin XL; Fan HB; Wang HX
    Oncol Rep; 2015 Oct; 34(4):1883-94. PubMed ID: 26252353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
    Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients.
    Yu D; Li J; Han Y; Liu S; Xiao N; Li Y; Sun X; Liu Z
    Chin Med J (Engl); 2014; 127(8):1464-8. PubMed ID: 24762590
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Guo N; Zhang W; Zhang B; Li Y; Tang J; Li S; Zhao Y; Zhao Y; Xia H; Yu C
    Mol Clin Oncol; 2015 Sep; 3(5):1123-1128. PubMed ID: 26623063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of
    Tsyganov MM; Ibragimova MK; Garbukov EY; Tsydenova IA; Gaptulbarova KA; Dolgasheva DS; Zdereva EA; Frolova AA; Slonimskaya EM; Litviakov NV
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between TOP2A, RRM1, HER2, ERCC1 expression and response to chemotherapy in patients with non-muscle invasive bladder cancer.
    Liu Z; Xing L; Zhu Y; Shi P; Deng G
    Heliyon; 2022 Jun; 8(6):e09643. PubMed ID: 35711974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.
    Deng LL; Deng HB; Lu CL; Guo Y; Wang D; Yan CH; Lv X; Shao YX
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2097-105. PubMed ID: 24994038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study.
    Huang ZL; Cao X; Luo RZ; Chen YF; Zhu LC; Wen Z
    Oncol Lett; 2016 Jan; 11(1):299-305. PubMed ID: 26870207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of ERCC1, RRM1, TOP1, TOP2A, TYMS, TUBB3, GSTP1 AND BRCA1 mRNA expressions in patients with non-small-cell lung cancer receiving a platinum-based chemotherapy.
    M Tsyganov M; O Rodionov E; M Pevzner A; K Ibragimova M; V Miller S; V Cheremisina O; G Frolova I; A Tuzikov S; V Litviakov N
    J BUON; 2020; 25(4):1728-1736. PubMed ID: 33099907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy.
    Leng XF; Chen MW; Xian L; Dai L; Ma GY; Li MH
    J Exp Clin Cancer Res; 2012 Mar; 31(1):25. PubMed ID: 22439756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapy.
    Qiao H; Huang X; Guo H; Liu Y; Yue C
    Pak J Med Sci; 2014; 30(6):1403-8. PubMed ID: 25674147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between clinical-pathological parameters and biomarkers, HER-2, TYMS, RRMI, and 21-gene recurrence score in breast cancer.
    Zhou YH; Liu Y; Zhang W; Liu C; He JJ; Tang XJ
    Pathol Res Pract; 2019 Nov; 215(11):152644. PubMed ID: 31551176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.